Erratum To: Adaptability of the semi‐invariant natural killer T‐cell receptor towards structurally diverse CD1d‐restricted ligands
William C. Florence(Vanderbilt University), Sebastian Joyce(Walther Cancer Foundation), Lars Kjer‐Nielsen(The University of Melbourne), Laura E. Gordy(Vanderbilt University), Wenlan Chen(The Ohio State University), James McCluskey(Peter Doherty Institute), Karl O. A. Yu(Jacobs (United States)), Laurent Gapin(National Jewish Health), Amy R. Howell(University of Connecticut), Onisha Patel(Monash University), James Scott‐Browne(National Jewish Health), Peng George Wang(Southern University of Science and Technology), Dirk M. Zajonc(La Jolla Institute for Immunology), Yalong Zhang(Dartmouth College), Yuki Kinjo(Jikei University School of Medicine), Stewart K. Richardson(University of Connecticut), Dale I. Godfrey(Peter Doherty Institute), Daniel G. Pellicci(The University of Melbourne), Jamie Rossjohn(Institute of Infection and Immunity), Chengfeng Xia(The Ohio State University), Santosh Keshipeddy(University of Connecticut), Kyoko Hayakawa(Fox Chase Cancer Center), Steven A. Porcelli(Albert Einstein College of Medicine)
Cited by 5
Related Papers
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.
|The Journal of Experimental Medicine|1991|1.6k
B Cell Development Pathways
|Annual Review of Immunology|2001|1.2k
More than one reason to rethink the use of peptides in vaccine design
|Nature Reviews Drug Discovery|2007|860
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.
|The Journal of Experimental Medicine|1983|804